3. 结构
3.1 二维结构
3.2 三维结构
-1
-2
-3
25 26 0 0 0 0 0 0 0999 V2000
0.8510 0.8262 -0.2813 N 0 0 0 0 0 0 0 0 0 0 0 0
4.9249 -0.9844 0.3395 N 0 0 0 0 0 0 0 0 0 0 0 0
2.8276 0.2113 -0.6529 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1708 1.3167 0.1859 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4731 -0.4990 -0.5205 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0876 0.7516 0.8398 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4334 0.2624 0.4221 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9927 -0.4529 -0.1017 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4096 1.1708 0.0125 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7159 -1.1033 0.4414 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.6683 0.7135 -0.3776 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.9746 -1.5607 0.0511 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9507 -0.6522 -0.3583 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0105 0.5432 -1.6860 H 0 0 0 0 0 0 0 0 0 0 0 0
2.3529 1.2401 1.2666 H 0 0 0 0 0 0 0 0 0 0 0 0
2.4070 2.3385 -0.1287 H 0 0 0 0 0 0 0 0 0 0 0 0
1.1259 -1.0017 -1.4294 H 0 0 0 0 0 0 0 0 0 0 0 0
1.4252 -1.2179 0.3085 H 0 0 0 0 0 0 0 0 0 0 0 0
-0.2055 1.7588 1.2638 H 0 0 0 0 0 0 0 0 0 0 0 0
0.2871 0.1420 1.6748 H 0 0 0 0 0 0 0 0 0 0 0 0
-2.2026 2.2375 -0.0094 H 0 0 0 0 0 0 0 0 0 0 0 0
-0.9687 -1.8235 0.7631 H 0 0 0 0 0 0 0 0 0 0 0 0
-4.4282 1.4206 -0.6969 H 0 0 0 0 0 0 0 0 0 0 0 0
-3.1952 -2.6240 0.0673 H 0 0 0 0 0 0 0 0 0 0 0 0
-4.9308 -1.0084 -0.6620 H 0 0 0 0 0 0 0 0 0 0 0 0
1 4 1 0 0 0 0
1 5 1 0 0 0 0
1 6 1 0 0 0 0
2 8 3 0 0 0 0
3 4 1 0 0 0 0
3 5 1 0 0 0 0
3 8 1 0 0 0 0
3 14 1 0 0 0 0
4 15 1 0 0 0 0
4 16 1 0 0 0 0
5 17 1 0 0 0 0
5 18 1 0 0 0 0
6 7 1 0 0 0 0
6 19 1 0 0 0 0
6 20 1 0 0 0 0
7 9 2 0 0 0 0
7 10 1 0 0 0 0
9 11 1 0 0 0 0
9 21 1 0 0 0 0
10 12 2 0 0 0 0
10 22 1 0 0 0 0
11 13 2 0 0 0 0
11 23 1 0 0 0 0
12 13 1 0 0 0 0
12 24 1 0 0 0 0
13 25 1 0 0 0 0
4. 国际命名与标识
4.1 IUPAC Name
1-benzylazetidine-3-carbonitrile
4.2 InChl
InChI=1S/C11H12N2/c12-6-11-8-13(9-11)7-10-4-2-1-3-5-10/h1-5,11H,7-9H2
4.3 InChlKey
JWARBUNVUNGRQE-UHFFFAOYSA-N
4.4 Canonical SMILES
C1C(CN1CC2=CC=CC=C2)C#N
4.5 lsomeric SMILES
-
4.6 SDF文件
5. 波谱数据
5.1 13C核磁共振谱(13C NMR)
5.2 1H核磁共振谱(1H NMR)
5.3 质谱(MS)
5.4 红外光谱(IR)
5.5 紫外/可见光谱(UV/Vis)
6. 相关药材
7. 相关靶点
8. 相关疾病